Initial Management of Asthma Exacerbation in the ICU

Immediate Recognition and Assessment

The American Thoracic Society recommends immediate administration of high-flow oxygen to maintain SaO₂ >90% (>95% in pregnant patients or those with heart disease), nebulized albuterol 2.5-5 mg every 20 minutes for 3 doses combined with ipratropium bromide 0.5 mg, and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) for patients with severe asthma exacerbation requiring ICU-level care 1, 2, 3
Life-threatening features requiring ICU admission include PEF <33% of predicted or personal best, silent chest, cyanosis, or feeble respiratory effort, altered mental status, confusion, or coma, PaCO₂ ≥42 mmHg, inability to speak in complete sentences, and bradycardia, hypotension, or exhaustion 2, 4, 3

The British Thoracic Society recommends administering high-flow oxygen (40-60%) via face mask or nasal cannula to maintain SaO₂ >90% (>95% in pregnant patients or those with cardiac disease) 2, 4, 3
The American College of Chest Physicians recommends nebulizer dosing of albuterol: 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed 1, 6, 3
The National Asthma Education and Prevention Program recommends adding ipratropium 0.5 mg to albuterol every 20 minutes for 3 doses, then as needed 1, 6, 3

The American College of Allergy, Asthma, and Immunology recommends administering systemic corticosteroids immediately, with clinical benefits may not appear for 6-12 hours, making early administration essential 6, 7, 3
The European Respiratory Society recommends oral prednisolone 30-60 mg daily (preferred route) or IV hydrocortisone 200 mg, then 200 mg every 6 hours if patient cannot tolerate oral route 2, 4, 7, 3

The American Thoracic Society recommends measuring PEF or FEV₁ and assessing symptoms/vital signs 15-30 minutes after starting treatment, and repeating assessment after each of the first two albuterol treatments and again 40 minutes after completing the initial 3 doses 2, 4, 3
The British Thoracic Society recommends continuous pulse oximetry, PEF or FEV₁ before and after each treatment, respiratory rate, heart rate, accessory muscle use, and arterial blood gas if PEF <25% predicted, severe distress, or suspected hypoventilation 3, 1

The American College of Allergy, Asthma, and Immunology recommends considering intravenous magnesium sulfate for life-threatening exacerbations or severe exacerbations remaining after 1 hour of intensive conventional treatment, with adult dose: 2 g IV over 20 minutes, and pediatric dose: 25-75 mg/kg (maximum 2 g) IV over 20 minutes 1, 6, 3
The National Asthma Education and Prevention Program recommends heliox-driven albuterol nebulization for severe refractory cases to decrease work of breathing, but evidence is limited by small trial sizes and methodological differences 6

The American Thoracic Society recommends recognizing signs requiring immediate intubation consideration, including inability to speak, altered mental status or worsening confusion, intercostal retraction with worsening fatigue, PaCO₂ ≥42 mmHg or rising, and exhaustion despite maximal therapy 1, 6
The European Respiratory Society recommends ensuring adequate intravascular volume replacement, using "permissive hypercapnia" ventilator strategy, and consulting with or comanaging by a physician expert in ventilator management 6